Fujirebio Diagnostics buys ABT
This article was originally published in The Gray Sheet
Executive Summary
Maker of cancer diagnostics and biomarker assays integrates its supplier of in vitro diagnostic assay controls and calibrators through the acquisition of American Biological Technologies, announced April 2. The deal marks Fujirebio's entry into the controls and calibrators manufacturing business, the firm says